Pharmaceutical giant Pfizer has just revealed that its revenue dropped dramatically in the first quarter of 2023. The drop is primarily due to COVID-19 vaccine sales plummeting. The company reported $18.3 billion in revenue. The figure is a significant drop from the $25.6 billion the company raked in during the…
